The Life Industry 1997: The Global Enterprises that Dominate Commercial Agric., Food, and Health in 1997 - an overview
Briefings
HGDP Rejected
Tuesday 30th September 1997
The life industry and US government are using bilateral bioprospecting agreements as their tool of choice to cheaply access genetic resources and undervalue farmers' resources and knowledge. These bilaterial agreements actually encourage inequities through patents, secrecy, and imbalanced negotiations that favour companies, not the true innovators and sustainable users of diversity, farmers and indigenous people.
Thursday 31st July 1997
The world's largest and most influential international agricultural research network, the Consultative Group on International Agricultural Research (CGIAR), is conducting its first full systemwide review in 17 years. In May, 1998 in Brayil, a prestigious review panel led by Maurice Strong will table its recommendations for the future of the network, which launched the Green Revolution.
Critical Crops; Patent Claims on Cloning
Saturday 31st May 1997
Will governments opt for a multilateral system of crop germplasm exchange or will they determine to pursue bilateral agreements between countries and companies? RAFI examines Africa's bargaining position, and concludes that bilateral negotiations over crop germplasm will benefit the North, at the expense of food security in the South.
Gene Licensing Agreements; Precision Farming
Monday 31st March 1997
Two trends in industrial agriculture are contributing to the erosion of farmers' rights and lead to bioserfdom: 1) Monsanto's 1996 gene licensing agreement; 2) "Precision farming" and the role it plays in the commodification of information technology and the growing influence of the life industry in farm-level decision-making.
Friday 14th February 1997
This map illustrates the transfer of human tissues through third countries. This graphic is part of the Communique on Human Tissue Trade.
The Global Traffic and Market in Human Biomaterials
Friday 31st January 1997
Despite the promise of medical breakthroughs, the utilization of human tissue prompts intense ethical concerns regarding ownership of human biomaterials, eugenics, discrimination and medical confidentiality. A large and growing South to North and North to North movement of human tissue is taking place in an almost total policy and regulatory vacuum.
Bolivian Quinoa Claimed in US Patents
Sunday 29th December 1996
"Biopiracy" -- a term coined by RAFI in 1994 - refers to the use of intellectual property laws to gain exclusive monopoly control over genetic resources that are based on the knowledge and innovation of farmers and indigenous peoples. This issue examines a patent claim on Bolivian quinoa, a US patent on turmeric, and more.
New IPR Resource Kit Available. U.S. Equivocates on Hagahai Patent
Sunday 29th September 1996
This is RAFI's first annual update on the "Life Industry" - the giant transnational enterprises that use, buy, sell and control an ever-growing market share of bio-industrial products relating to food, agriculture and health. A list of the top 10 corporations, ranked by 1995 sales, is given for each sector.
Cotton "Failing in the Field"
Wednesday 31st July 1996
Pharmaceutical firms and biotech companies are approaching botanical gardens to buy samples of tropical plant diversity - a clear violation of the spirit - if not the law - of the Convention on Biological Diversity. The rights of farmers and indigenous peoples are being bypassed by corporate deals that make a mockery of the CBD's fundamental principles.
Pages
